MSP Recovery’s Claims Dismissed in Fresenius Granuflo/NaturaLyte MDL

  • Order

BOSTON — A Massachusetts federal judge has dismissed a third-party payor assignee’s claims accusing Fresenius of failing to warn that its dialysis product Granuflo can cause heart attacks, ruling that they are untimely.

In a Sept. 7 order, Judge Nathaniel M. Gorton of the U.S. District Court for the District of Massachusetts ruled that MSP Recovery Inc. is not entitled to class action tolling because it failed to establish that it is a member of an original putative class in the Fresenius Granuflo/NaturaLyte MDL.

Medicare payers, first-tier, downstream, and related entities assigned MSP Recovery the right to recover direct economic …


HarrisMartin's New Jersey Asbestos Litigation Conference

March 01, 2024 - New Brunswick, NJ
Hyatt Regency New Brunswick


HarrisMartin’s Benzene and Toxic Tort Litigation Conference: Recent Developments and Future Trends

December 01, 2023 - Charleston, SC
The Charleston Place